Assessing the disease-liability of mutations in CFTR

Claude Ferec, Garry R Cutting

Research output: Contribution to journalArticle

Abstract

Over 1900 mutations have been reported in the cystic fibrosis transmembrane conductance regulator (CFTR), the gene defective in patients with cystic fibrosis. These mutations have been discovered primarily in individuals who have features consistent with the diagnosis of CF. In some cases, it has been recognized that the mutations are not causative of cystic fibrosis but are responsible for disorders with features similar to CF, and these conditions have been termed CFTR-related disorders or CFTR-RD. There are also mutations in CFTR that do not contribute to any known disease state. Distinguishing CFTR mutations according to their penetrance for an abnormal phenotype is important for clinical management, structure/function analysis of CFTR, and understanding the molecular and cellular mechanisms underlying CF.

Original languageEnglish (US)
Article numbera009480
JournalCold Spring Harbor perspectives in medicine
Volume2
Issue number12
DOIs
StatePublished - 2012

Fingerprint

Cystic Fibrosis Transmembrane Conductance Regulator
Mutation
Cystic Fibrosis
Penetrance
Regulator Genes
Genes
Phenotype

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Assessing the disease-liability of mutations in CFTR. / Ferec, Claude; Cutting, Garry R.

In: Cold Spring Harbor perspectives in medicine, Vol. 2, No. 12, a009480, 2012.

Research output: Contribution to journalArticle

@article{e6fd2761bd31474ba488e760808ba126,
title = "Assessing the disease-liability of mutations in CFTR",
abstract = "Over 1900 mutations have been reported in the cystic fibrosis transmembrane conductance regulator (CFTR), the gene defective in patients with cystic fibrosis. These mutations have been discovered primarily in individuals who have features consistent with the diagnosis of CF. In some cases, it has been recognized that the mutations are not causative of cystic fibrosis but are responsible for disorders with features similar to CF, and these conditions have been termed CFTR-related disorders or CFTR-RD. There are also mutations in CFTR that do not contribute to any known disease state. Distinguishing CFTR mutations according to their penetrance for an abnormal phenotype is important for clinical management, structure/function analysis of CFTR, and understanding the molecular and cellular mechanisms underlying CF.",
author = "Claude Ferec and Cutting, {Garry R}",
year = "2012",
doi = "10.1101/cshperspect.a009480",
language = "English (US)",
volume = "2",
journal = "Cold Spring Harbor perspectives in medicine",
issn = "2157-1422",
publisher = "Cold Spring Harbor Laboratory Press",
number = "12",

}

TY - JOUR

T1 - Assessing the disease-liability of mutations in CFTR

AU - Ferec, Claude

AU - Cutting, Garry R

PY - 2012

Y1 - 2012

N2 - Over 1900 mutations have been reported in the cystic fibrosis transmembrane conductance regulator (CFTR), the gene defective in patients with cystic fibrosis. These mutations have been discovered primarily in individuals who have features consistent with the diagnosis of CF. In some cases, it has been recognized that the mutations are not causative of cystic fibrosis but are responsible for disorders with features similar to CF, and these conditions have been termed CFTR-related disorders or CFTR-RD. There are also mutations in CFTR that do not contribute to any known disease state. Distinguishing CFTR mutations according to their penetrance for an abnormal phenotype is important for clinical management, structure/function analysis of CFTR, and understanding the molecular and cellular mechanisms underlying CF.

AB - Over 1900 mutations have been reported in the cystic fibrosis transmembrane conductance regulator (CFTR), the gene defective in patients with cystic fibrosis. These mutations have been discovered primarily in individuals who have features consistent with the diagnosis of CF. In some cases, it has been recognized that the mutations are not causative of cystic fibrosis but are responsible for disorders with features similar to CF, and these conditions have been termed CFTR-related disorders or CFTR-RD. There are also mutations in CFTR that do not contribute to any known disease state. Distinguishing CFTR mutations according to their penetrance for an abnormal phenotype is important for clinical management, structure/function analysis of CFTR, and understanding the molecular and cellular mechanisms underlying CF.

UR - http://www.scopus.com/inward/record.url?scp=84877587139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877587139&partnerID=8YFLogxK

U2 - 10.1101/cshperspect.a009480

DO - 10.1101/cshperspect.a009480

M3 - Article

C2 - 23209179

AN - SCOPUS:84877587139

VL - 2

JO - Cold Spring Harbor perspectives in medicine

JF - Cold Spring Harbor perspectives in medicine

SN - 2157-1422

IS - 12

M1 - a009480

ER -